On Wednesday, European exchange-traded funds – the JPMorgan BetaBuilders Europe ETF BBEU,
the iShares MSCI Eurozone ETF EZU,
and the Vanguard FTSE Europe ETF VGK,
– represented three of the top eight equity funds purchased by US investors. European equity ETFs saw inflows of $ 7.6 billion from U.S. investors in 2021, according to FactSet data.
Jefferies analysts say their monitoring of European activity was at 85% of pre-COVID-19 levels. “The eurozone economy continues to rebound, with the latest Ifo [Institute for Economic Research] and INSEE [National Institute of Statistics and Economic Studies] surveys indicating a significant improvement in business confidence in Germany and France, led by the service sector, ”they said, recommending payment company Adyen, ADYEN,
bank focused on payments Nexi NEXI,
and the automobile manufacturer Stellantis STLA,
as a means of playing recuperation.
That said, the stock market performance has been roughly the same on both sides of the Atlantic. In dollars, the Stoxx Europe 600 climbed 12% in 2021, as did the S&P 500 SPX,
The market as a whole was sluggish again on Thursday. The Stoxx Europe 600 SXXP,
rose 0.2%, while US equity futures ES00,
were slightly lower.
the shares jumped 6%, as the aircraft manufacturer planned to increase production. Of 45 narrow-body A320 aircraft per month in the fourth quarter, the Boeing BA,
rival plans to increase production to 64 by the second quarter of 2023 and is exploring possibilities to increase production to 75 by 2025. Airbus also said it will increase production of two more models, the A220, which is the smallest aircraft it manufactures. and the A350 jet.
shares fell 4%, after a U.S. judge rejected the company’s plans to set aside $ 2 billion for people who are not yet sick or have yet to sue after having contracted cancer while using Roundup weedkiller. Bayer says it could remove the product from the United States entirely for retail users.
Tate and Lyle TATE,
Shares fell 4%, after forecasting a decline in adjusted earnings per share due to declining profitability at its commodities business and an increase in the tax rate, as it also said its artificial sweeteners manufacturing unit was still on the market.